NPPES file of Aug 9, 2026

Anna Tumyan, M.D.

Endocrinology, Diabetes & Metabolism Physician · Dallas, TX

Anna Tumyan, M.D. is an endocrinology, diabetes & metabolism physician with a practice address in Dallas, Texas, and NPI 1649463076, issued on Aug 20, 2007. Check the license (Texas N9657, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1649463076
Name
Anna Tumyan
Credential
M.D.
Primary taxonomy
Endocrinology, Diabetes & Metabolism Physician 207RE0101X
License number
N9657 TX
Self-reported in NPPES; status is on the state search
Practice location
5323 Harry Hines Blvd, Dallas, TX 75390
Phone
(214) 645-2800
Enumerated
Aug 20, 2007
Record last updated
Aug 17, 2016 (not updated in 10 years: call before relying on the address or phone)
Fax
(214) 645-0078
Medicare enrollment
Enrolled (PECOS I20160815001501); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 5323 Harry Hines Blvd

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Ali Abbas, MDStudent in an Organized Health Care Education/Training Program1447822507
  2. Laila Abbas, MDStudent in an Organized Health Care Education/Training Program1861132524
  3. Eileen Abbasi, CRNACertified Registered Nurse Anesthetist1588918981
  4. Mina Abbassi-Ghanavati, MDObstetrics & Gynecology Physician1154509610
  5. Abier Abdelnaby, M.D.Colon & Rectal Surgery Physician1831312503
  6. Ahmed AbdiStudent in an Organized Health Care Education/Training Program1952095184

Verify Anna Tumyan in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersTexas Medical Board
    Search for license N9657
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Texas license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

94% more Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

5,112 Medicare Part D claims for 560 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 55% of claims.

  1. Anna Tumyan5,112
  2. Specialty average2,630

Most prescribed

  1. Levothyroxine Sodium828 claims
  2. Ozempic396 claims
  3. Metformin Hcl315 claims
  4. Synthroid240 claims
  5. Mounjaro229 claims
  6. Atorvastatin Calcium208 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 74.6 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score56.1
  2. Costout of 100 · 30%59.2
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $7.11

1 payment: food and beverage; the largest payer was Beta Bionics, Inc. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Anna Tumyan$7.11
  2. Specialty average$5,742.15

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. University OF Texas Southwestern Medical Center AT DallasDallas, TX

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Anna Tumyan among 743 endocrinology, diabetes & metabolism physician records in Texas

Anna Tumyan, M.D. is one of 743 endocrinology, diabetes & metabolism physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 39% of them.

  • NPI issued2007 · 39% of these records are older, 48% newer
  • In a Medicare fileYes · 87% of these records are
  • In the CMS Doctors and Clinicians fileYes · 75% of these records are
  • Graduated1999 · median 2004 among the 560 with a school on file
  • Record last updated2016 · 50% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Endocrinology, Diabetes & Metabolism Physician providers in Texas

There are 743 endocrinology, diabetes & metabolism physician records in Texas.

The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes

  1. Perry Bickel, M.D.Dallas, TX 753901285651737
  2. Alberto Cabo Chan, MDDallas, TX 753901750314449
  3. Abhimanyu Garg, MDDallas, TX 753901871562355
  4. Ildiko Lingvay, MDDallas, TX 753901447216916
  5. Naim Maalouf, M.D.Dallas, TX 753901811956188
  6. David McFadden, M.D.Dallas, TX 753901962458174
  7. Michael McPhaul, MDDallas, TX 753901730146168
  8. Luigi Meneghini, M.D.Dallas, TX 753901245295831

Common questions

What is Anna Tumyan, M.D.'s NPI number?

Anna Tumyan, M.D.'s National Provider Identifier (NPI) is 1649463076, issued on Aug 20, 2007. An NPI identifies a provider in billing; it is not a license.

Where is Anna Tumyan, M.D. located?

The NPPES record lists a practice address at 5323 Harry Hines Blvd, Dallas, TX, 75390. Phone: (214) 645-2800. Providers update this record themselves, so call before visiting.

How can I verify Anna Tumyan, M.D.'s license?

NPPES lists Texas license number N9657, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Anna Tumyan, M.D. prescribe under Medicare Part D?

In 2024, Anna Tumyan, M.D. had 5,112 Medicare Part D claims for 560 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.

What is Anna Tumyan, M.D.'s MIPS final score?

The 2023 MIPS final score is 74.6 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.